Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
基本信息
- 批准号:10740465
- 负责人:
- 金额:$ 24.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-08-30
- 项目状态:未结题
- 来源:
- 关键词:Adaptive Immune SystemAdoptive TransferAffectAnatomyAnterior uveitisAntigen PresentationAntigen-Presenting CellsAntigensAqueous HumorAreaArrestinsAutoimmune DiseasesAutoimmune ProcessAutoimmunityAutomobile DrivingBenignBlindnessBlood VesselsCD4 Positive T LymphocytesCNS autoimmunityCXCR6 geneCell Adhesion MoleculesCellsCentral Nervous SystemChoroidCirculationClinicalDataData SetDevelopmentDevelopment PlansDiagnostic testsDiseaseDoctor of PhilosophyDrainage procedureEnvironmentEnzyme-Linked Immunosorbent AssayExperimental ModelsEyeEye diseasesFlow CytometryFundingFutureGene Expression ProfileGoalsHistologicICAM1 geneImageImmuneImmune responseImmune systemImmunityImmunohistochemistryImmunologic SurveillanceImmunologyInflammationInflammatoryInstitutionKnock-inKnowledgeLearningLymphaticLymphocyteMeasuresMediatorMedicalMedical ResearchMemoryMeningesMentorsMentorshipMethodsModelingMolecularMusNerve DegenerationNeurosciencesOperative Surgical ProceduresOphthalmologyOutcomeOvalbuminPapillaryPathogenesisPathogenicityPatient CarePeripheralPharmaceutical PreparationsPlayPopulationPrincipal InvestigatorProcessProductivityRecurrent diseaseResearchResearch PersonnelRetinaRoleRouteScientistSeveritiesSignal TransductionSourceStructure of retinal pigment epitheliumSystemic TherapyT cell responseT-Cell ActivationT-LymphocyteTestingTissuesTrainingUnited StatesUniversitiesUveitisWashingtonWorkadaptive immune responseantigen-specific T cellsautoimmune uveitisautoreactive T cellaxon injurybasebrain parenchymacareercareer developmentcell behaviorcell motilitychemokinechemokine receptorclinical trainingcytokinedifferential expressionimprovedin vivo imagingintravital microscopyknowledge basemigrationmonocytemulti-photonnovelprogramsresearch and developmentresponseskill acquisitionskillstargeted treatmenttraffickingvision science
项目摘要
Project summary:
The overarching goal of this project is to develop the principal investigator (PI) into an independent clinician-
scientist contributing to the field of ocular autoimmunity. The PI has obtained his PhD in neuroscience, exploring
the roles of the adaptive immune system in axonal injury models. He has additional clinical training in
ophthalmology and subspecialty training in uveitis and ocular immunology, which forms the basis for his medical
practice in the Department of Ophthalmology and Visual Sciences at Washington University in St. Louis. The
five-year career development plan outlined here will utilize a combination of didactic courses, individualized
training from expert collaborators, and mentorship from established investigators to enhance his knowledge
base, to learn new experimental models he can continue to use in his career, and to define the research
questions on which he will base the start of his independent research program. By the end of this program, he
will have acquired the skills necessary to become an independent investigator.
His primary mentor is Rajendra Apte, MD PhD, an R01-funded investigator who has a longitudinal track record
of training early-stage investigators that have gone on to productive independent careers. He is a preeminent
scholar in the field of choroidal immunity and has a strong background as a clinician scientist that will be vital for
helping the PI navigate the challenges involved in transitioning to an independent lab. Dr. Apte will be supported
by Rachel Caspi, PhD, the world-leading expert in experimental autoimmune uveitis, Jonathan Kipnis, PhD, the
foremost expert in the adaptive immune system in border tissues, and Gregory Wu, MD PhD, a recent K08
awardee and expert on CNS autoimmunity. The PI will take advantage of his mentorship committee and the
vibrant scientific environment of Washington University, one of the world’s premiere medical research
institutions, to develop the unexplored topic of the adaptive immune response in the choroid.
Uveitis is one of the leading causes of preventable blindness, and while much work has gone in to evaluating
the effects of T cell-derived cytokines, there is a significant gap in understanding of the anatomy of the immune
response including where the adaptive immune system interfaces with ocular antigens. This deficit has led to
toxic and often ineffective systemic therapies as the mainstay of treatment. We show that intraocular antigens
are taken up in the choroid, a tissue that has a rich adaptive immune presence. In autoimmune uveitis there is
an increase of CD4+ T cells in the choroid, indicating that the choroid plays a vital role as the immune interface
between the intraocular space and adaptive immune system. In this proposal, we will test the hypothesis that
the adaptive immune system is activated by retinal antigens in the choroid and that this interaction plays a central
role in uveitis. We will further elucidate the mechanisms contributing to immune surveillance in the choroid.
Understanding the mechanisms behind this process has broad implications in the development of diagnostic
testing and targeted therapy that will improve the clinical outcomes in uveitis.
项目概要:
该项目的总体目标是将主要研究者(PI)培养为独立的临床医生-
对眼部自身免疫领域做出贡献的科学家。PI获得了神经科学博士学位,探索
适应性免疫系统在轴突损伤模型中的作用。他还接受了以下方面的临床培训:
眼科和葡萄膜炎和眼免疫学的亚专业培训,这构成了他的医学基础。
在圣路易斯的华盛顿大学眼科和视觉科学系实习。的
这里概述的五年职业发展计划将利用教学课程的组合,个性化
来自专家合作者的培训,以及来自知名调查人员的指导,以提高他的知识
基地,学习新的实验模型,他可以继续在他的职业生涯中使用,并定义研究
他将以此为基础开始他的独立研究计划。在节目结束时,他
将获得成为独立调查员所需的技能。
他的主要导师是Rajendra Apte,医学博士,R 01资助的研究人员,有纵向跟踪记录
培训早期的调查人员,他们已经开始了富有成效的独立职业生涯。他是一位杰出的
他是脉络膜免疫领域的学者,并具有作为临床科学家的强大背景,这对于
帮助PI应对过渡到独立实验室所涉及的挑战。Apte博士将得到支持
由Rachel Caspi博士,世界领先的实验性自身免疫性葡萄膜炎专家,Jonathan Kipnis博士,
最重要的专家在适应性免疫系统在边界组织,和格雷戈里吴,医学博士,博士,最近的K 08
获奖者和中枢神经系统自身免疫专家。PI将利用他的导师委员会和
华盛顿大学充满活力的科学环境,世界上首屈一指的医学研究之一
机构,发展脉络膜适应性免疫反应的未探索的主题。
葡萄膜炎是可预防性失明的主要原因之一,虽然许多工作已经在评估
T细胞衍生的细胞因子的作用,在理解免疫系统的解剖结构方面存在着重大的差距。
免疫应答包括适应性免疫系统与眼抗原相互作用的地方。这一赤字导致
毒性和通常无效的全身疗法作为治疗的主要手段。我们发现眼内抗原
被脉络膜吸收,脉络膜是一种具有丰富适应性免疫存在的组织。在自身免疫性葡萄膜炎中,
脉络膜中CD 4 + T细胞的增加,表明脉络膜作为免疫界面起着至关重要的作用
眼内空间和适应性免疫系统之间的关系。在本提案中,我们将检验以下假设:
适应性免疫系统被脉络膜中的视网膜抗原激活,
在葡萄膜炎中的作用我们将进一步阐明脉络膜免疫监视的机制。
了解这一过程背后的机制对诊断性疾病的发展具有广泛的意义。
测试和靶向治疗,将改善葡萄膜炎的临床结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James Walsh其他文献
James Walsh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 24.03万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 24.03万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 24.03万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 24.03万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 24.03万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 24.03万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 24.03万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 24.03万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 24.03万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 24.03万 - 项目类别: